Truist Securities Maintains Hold on Teladoc Health, Raises Price Target to $9
Benzinga Newsdesk 9 hours ago
Analyst RatingsNewsPrice Target
This page contains a summary, not the full article. Continue to benzinga.com to read the original report.
Truist Securities analyst Jailendra Singh maintains Teladoc Health (NYSE:TDOC) with a Hold and raises the price target from $8 to $9.
Truist Securities analyst Jailendra Singh maintains Teladoc Health (NYSE:TDOC) with a Hold and raises the price target from $8 to $9.
